Our innovative technology platforms have led to collaborations with leading pharmaceutical companies:
Worldwide Licensing Agreement with Pfizer Inc. for Dekavil, an Investigational Immunoregulatory Therapy for Autoimmune Diseases.
Collaboration with Pfizer Inc. in the field of cancer target discovery.
Collaboration with Merck Serono for the generation of monoclonal antibodies to be used in the search for molecular biomarkers.
Collaboration with MedImmune on Encoded Self-Assembling Chemical Libraries
For additional information about partnering opportunities, please contact:
Dr. Jane Wilton, Director of Business Development